Waters QTof Mass Spectrometer Detects Low-Level Compounds

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-09-02-2014
Volume 38
Issue 9

The Waters Xevo G2-XS mass spectrometer is a new high-performance benchtop quadrupole time-of-flight (QTof) mass spectrometer that combines the new XS Collision Cell with the technologies of Tof-MRM, StepWave and QuanTof for sensitivity and selectivity that allows detection of low-level compounds.

The Waters Xevo G2-XS mass spectrometer is a new high-performance benchtop quadrupole time-of-flight (QTof) mass spectrometer that combines the new XS Collision Cell with the technologies of Tof-MRM, StepWave and QuanTof for sensitivity and selectivity that allows detection of low-level compounds.

The benchtop instrument allows laboratories to perform qualitative and quantitative experiments for both known and unknown analytes. For targeted quantitative experiments, Tof-MRM mode delivers a 10-fold improvement in signal-to-noise when compared to full scan mode, thus improving limits of detection and quantification. The instrument uses Waters MSE technology, a patented method of data acquisition that comprehensively catalogs complex samples in a single analysis.

ref="http://www.waters.com/qtof" target="_blank" ref="nofollow">Waters

Recent Videos
Drug Digest: Strategic Partnerships
Michelle Bridenbaker from Unbiased Science discusses her thoughts on the key industry from 2024 and those she anticipates will impact the industry in 2025 and beyond.
Henny Zijlstra from Adragos Pharma chats about the trends affecting the outsourcing market, various strategies being employed by service providers, and the value of end-to-end services.
Related Content